ki 1769 has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsushita, Y; Nagai, J; Neyama, H; Tsukahara, R; Tsukahara, T; Ueda, H | 1 |
| Izawa, T; Izumi, H; Kawahara, J; Ogawa, N; Takeuchi, A | 1 |
2 other study(ies) available for ki 1769 and Disease Models, Animal
| Article | Year |
|---|---|
Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain.
Topics: 2-Aminoadipic Acid; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Chemokine CXCL1; Disease Models, Animal; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Neuralgia; Pain Measurement; Pain Threshold; Pyridines; RNA, Messenger; Sciatic Neuropathy; Spinal Cord; Up-Regulation | 2018 |
In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Glyburide; Heart Rate; Hypertension; In Vitro Techniques; Injections, Intravenous; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels; Pyridines; Rats; Rats, Wistar; Structure-Activity Relationship; Vasodilator Agents | 1997 |